Erectile Dysfunction and Heart Disease: An Early Warning

Erectile dysfunction shares risk factors with cardiovascular disease. The association can support a health review, but it cannot determine one person’s diagnosis or future.

6 min read
July 22, 2026
Sexual WellnessMen's HealthCardiovascular HealthMetabolic HealthWellspan
On this page0% read

Start Here

New or worsening erectile dysfunction (ED) can be associated with cardiovascular disease because erections depend on healthy blood vessels. It does not prove that heart disease is present, and ED also has neurologic, hormonal, medication-related, psychological, and relationship causes. A persistent change deserves both an ED evaluation and a review of cardiovascular risk.

What to do with a new change

Schedule an evaluation

A persistent new or worsening pattern is worth discussing with a clinician.

Put the association in context

ED raises cardiovascular risk at a group level but does not determine your individual diagnosis.

Review common risks

Blood pressure, cholesterol, blood sugar, smoking, medications, sleep, and symptoms guide the workup.

Treat ED at the same time

Symptom treatment can proceed while the clinician evaluates possible causes and cardiovascular risk.

A change may mean erections take longer, are less firm, or occur less reliably. Morning erections may also become less frequent. The duration, consistency, circumstances, and associated symptoms help determine what should be checked.

What a change in your erections is telling you

ED is an independent marker of cardiovascular risk in population studies 1. The 2024 Princeton IV consensus recommends cardiovascular-risk assessment for men with ED, including those without known heart disease 10. This recommendation supports evaluation; it does not mean every man with ED has blocked arteries.

ED also matters because it affects sexual function and quality of life. Evaluating cardiovascular risk and treating the erectile problem are complementary parts of care.

An erection runs on the same arteries as your heart

An erection requires nerves, hormones, sexual stimulation, and increased blood flow. The vascular connection to heart disease involves the endothelium, the inner lining that helps blood vessels relax.

The artery-size hypothesis

One leading hypothesis proposes that the same vascular injury becomes symptomatic earlier in smaller penile arteries than in larger coronary arteries 2. This may help explain why ED can precede diagnosed heart disease. It is a biologic explanation for an observed association, not proof of a fixed sequence in every person.

High blood pressure, diabetes, smoking, and unfavorable cholesterol can damage blood vessels throughout the body. When reduced blood flow contributes to ED, clinicians may call it vasculogenic erectile dysfunction. These risk factors also raise the likelihood of cardiovascular disease.

The evidence supports shared vascular mechanisms and a consistent association between ED and cardiovascular disease 9. It does not show that penile arteries follow a separate, predictable “clogging” schedule.

How early the signal shows up, and how strong it is

Prospective studies and pooled analyses quantify the association, but their estimates describe groups rather than an individual's future.

What the research supports

The question
How much risk does it carry?
What the research found
Pooled across 12 prospective studies, men with erectile dysfunction (ED) had about a 48% higher rate of cardiovascular events [4].
How to read it
This is a group-level relative increase, not a 48% personal probability. The association persisted after adjustment for several common risk factors.
The question
How early does it arrive?
What the research found
One study included men with documented coronary disease who also had ED. Two thirds said the erection problem came first, by about three years on average (range one month to fourteen years) [3].
How to read it
Participants recalled the timing after a heart diagnosis. The result describes an average sequence in that selected group, not a countdown for an individual.
The question
Does my age change it?
What the research found
In one longitudinal study, the association was strongest in younger men and had little predictive value after age 70 [6].
How to read it
Age changes the amount of added predictive information, but persistent ED at any age still deserves clinical evaluation.

In the original cohort, the association was similar in magnitude to current smoking or a family history of heart attack 1. In a separate multiethnic cohort followed for about four years, ED remained associated with events after adjustment for standard risk factors and depression 7.

Pooled cohort data also associated ED with a 25% higher all-cause mortality rate. Cardiovascular mortality did not reach statistical significance in the same analysis 5. These observational results do not show that treating ED extends life.

What a cardiometabolic workup covers

The evaluation begins with a medical and sexual history, medication review, physical examination, and assessment of cardiovascular risk. Testing is selected according to age, symptoms, and risk factors.

  • Blood pressure
    High blood pressure can contribute to both ED and cardiovascular disease.
  • A cholesterol panel
    Cholesterol results help estimate long-term cardiovascular risk.
  • Blood sugar
    Fasting glucose or hemoglobin A1c can identify diabetes or prediabetes when testing is appropriate.
  • Weight and waist
    Weight and waist measurement can add context about metabolic risk without explaining ED by themselves.
  • Smoking, alcohol, sleep, and medications
    Smoking, heavy alcohol use, poor sleep, and some medicines can contribute to ED or cardiovascular risk.

Our blood-biomarkers guide explains common lipid and blood-sugar tests. It is not a universal ED testing panel.

Consensus guidance focuses on identifying men with ED who may need additional cardiovascular assessment 8, 10. A clinician combines the ED history with established risk calculators, symptoms, examination findings, and test results.

Some men may be candidates for coronary-artery calcium scoring or another cardiac evaluation when their risk remains uncertain 10. Imaging is not necessary for every person with ED. Chest pain, shortness of breath, or symptoms with exertion require more urgent assessment.

A prompt to get checked, not a diagnosis

ED has vascular, neurologic, hormonal, medication-related, psychological, and relationship causes 11. More than one may be present. A clinician can also distinguish a persistent pattern from a situational episode and assess whether low testosterone testing is appropriate.

Treatment does not need to wait until every risk question is resolved. Common first-line medicines are PDE-5 inhibitors, including sildenafil (Viagra) and tadalafil (Cialis). They must not be combined with nitrate medicines because blood pressure can fall dangerously. Vacuum devices are another established option. Low-intensity shockwave therapy remains investigational rather than standard care.

Why this is worth acting on now

An ED visit can uncover untreated high blood pressure, diabetes, medication effects, or another contributor. Managing those conditions is valuable even if the erection problem has a different cause. Evidence has not shown that ED treatment itself extends life. The broader evaluation of desire, arousal, hormones, and relationships is covered separately.

The bottom line

Persistent new or worsening ED is associated with higher cardiovascular risk, especially in younger men, but it is not a heart-disease diagnosis. Arrange an ED evaluation and cardiovascular-risk review. Symptom treatment can proceed at the same time, with medicine choice based on safety and the likely cause.

References

  1. Thompson IM, et al. "Erectile dysfunction and subsequent cardiovascular disease." JAMA. 2005. PubMed
  2. Montorsi P, et al. "The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease." American Journal of Cardiology. 2005. PubMed
  3. Montorsi F, et al. "Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease." European Urology. 2003. PubMed
  4. Dong JY, et al. "Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies." Journal of the American College of Cardiology. 2011. PubMed
  5. Vlachopoulos CV, et al. "Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies." Circulation: Cardiovascular Quality and Outcomes. 2013. PubMed
  6. Inman BA, et al. "A population-based, longitudinal study of erectile dysfunction and future coronary artery disease." Mayo Clinic Proceedings. 2009. PubMed
  7. Uddin SMI, et al. "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis." Circulation. 2018. PubMed
  8. Nehra A, et al. "The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease." Mayo Clinic Proceedings. 2012. PubMed
  9. Gandaglia G, et al. "A systematic review of the association between erectile dysfunction and cardiovascular disease." European Urology. 2014. PubMed
  10. Köhler TS, et al. "The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease." Mayo Clinic Proceedings. 2024. PubMed
  11. Yafi FA, et al. "Erectile dysfunction." Nature Reviews Disease Primers. 2016. PubMed